Pharmagellan unlocks the true value in your biotech development pipeline.
Biotech companies typically develop deep research portfolios, but many promising early-stage projects don't progress if the team is stretched thin and focused on the lead asset.
To fully realize the value of projects under development, these companies need external support that is both senior-level and hands-on.
Pharmagellan offers just that: expert advice and project execution to biotech companies willing to discover how far they can go.
Preclinical, translational, and early clinical strategy and execution
Competitive and financial analysis of products, portfolios, and companies